Vegalab Inc. Announces New Auditors
RRBB Accountants and Advisors to Serve as the Company’s Accountants of Record
Nevada, April 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Vegalab, Inc. ("the Company"), (OTC: VEGL) an industry leader in the soft chemistry and natural agrochemical segment, today announced the retention of RRBB Accountants and Advisors to provide public accounting and advisory services. Founded in 1961 as Rosenberg Rich Baker Berman & Company, RRBB is one of the accounting profession’s most highly respected firms, with 11 partners and over 60 professional staffers serving clients across the U.S. and worldwide.
David Selakovic, CEO of Vegalab, Inc., stated, “RRBB Accountants & Advisors provides clients with old-fashioned accounting services combined with cutting edge practices. We were most impressed with the RRBB team, and we look forward to building a long term relationship with them. With RRBB leading our corporate auditing process, we expect to bring all of our SEC filings up to date in short order, and to remain fully compliant in our reporting responsibilities going forward.”
Vegalab, Inc. is the exclusive distributor in North and South America of a line of all-natural, biologically derived pesticides, fertilizers, and specialty agricultural products. Vegalab’s pesticides are highly effective against targeted organisms, non-toxic to beneficial organisms, and safe for the environment. Vegalab’s products support a healthy soil biome and are cost competitive with synthetic chemicals that do just the opposite. The Company operates in two segments of the food industry. The Agronomy Business involves the manufacture and distribution of all-natural crop protection, crop health, and soil enhancement products; the Packing Business involves the operation of citrus packing facilities.
Safe Harbor for Forward-looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements by words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “should,” “would” or similar words. You should consider these statements carefully because they discuss our plans, targets, strategies, prospects and expectations concerning our business, operating results, financial condition and other similar matters. These statements are subject to certain risks, uncertainties, and assumptions, including, but not limited to, risks and uncertainties relating to the Company’s ability to develop, market and sell products and services, based on its technology; the expected benefits and efficacy of the Company’s products, services and technology; the availability of additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and, the Company’s business, research, product development, regulatory approval, marketing and distribution plans and strategies; the ability of the Company to execute on a business plan that permits the technologies and innovations businesses to provide sufficient growth, revenue, liquidity and cash flows for sustaining the Company’s go-forward business, and the risks identified and discussed under the caption “Risk Factors” in the Vegalab Annual Report filed with the Securities and Exchange Commission (the “SEC”) and the other documents Vegalab files with the SEC from time to time. There will be events in the future, however, that Vegalab is not able to predict accurately or control. Vegalab’s actual results may differ materially from the expectations that Vegalab describes in its forward-looking statements. Factors or events that could cause Vegalab’s actual results to materially differ may emerge from time to time, and it is not possible for Vegalab to accurately predict all of them. Any forward-looking statement made by Vegalab in this press release speaks only as of the date on which Vegalab makes it. Vegalab undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Contacts: For Vegalab: Michael Husted T: 302-298-0888 ext. 712 Vegalab Investor Relations email@example.com (212) 389-9782 Ext. 101Source: Vegalab Inc.
Released April 23, 2019